ZUG, Switzerland, Nov. 13, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS) (Oculis), a worldwide biopharmaceutical firm purposefully pushed to save lots of sight and enhance eye care, at the moment introduced that Oculis’ administration will probably be current on the Stifel 2024 Healthcare Convention being held on November 18-19, 2024 on the Lotte New York Palace Lodge in New York, NY.
Sylvia Cheung, Chief Monetary Officer of Oculis, will take part in a hearth chat on November 18, 2024 at 3:35 pm ET. A stay webcast of the hearth chat will probably be accessible right here.
The Firm will probably be accessible for one-on-one conferences throughout the convention. traders ought to contact their Stifel consultant to request conferences. A hyperlink to entry the hearth chat, when accessible, will probably be posted to Oculis web site on the Occasions & Presentation web page below the Traders & Media part.
-ENDS-
About Oculis
Oculis is a worldwide biopharmaceutical firm (Nasdaq: OCS; XICE: OCS) purposefully pushed to save lots of sight and enhance eye care. Oculis’ extremely differentiated pipeline includes a number of progressive product candidates in improvement. It contains OCS-01, a topical eye drop candidate for diabetic macular edema (DME) and for the therapy of irritation and ache following cataract surgical procedure; licaminlimab (OCS-02), a topical biologic anti-TNFα eye drop candidate for dry eye illness (DED) and for non-infectious anterior uveitis; and OCS-05, a neuroprotective candidate for acute optic neuritis (AON). Headquartered in Switzerland and with operations within the U.S. and Iceland, Oculis’ objective is to enhance the well being and high quality of lifetime of sufferers worldwide. The corporate is led by an skilled administration workforce with a profitable monitor file and is supported by main worldwide healthcare traders.
For extra data, please go to: www.oculis.com
Oculis Contacts
Ms. Sylvia Cheung, CFO
sylvia.cheung@oculis.com
Investor & Media Relations
LifeSci Advisors
Corey Davis, Ph.D.
cdavis@lifesciadvisors.com
1-212-915-2577
